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Background: Few studies have investigated the service needs of persons who inject drugs (PWID) who live in less
populated regions of Canada. With access to fewer treatment and harm reduction services than those in more
urban environments, the needs of PWID in smaller centres may be distinct. As such, the present study examined
the needs of PWID in Prince Edward Island (PEI), the smallest of Canada's provinces.
Methods: Eight PWID were interviewed about the services they have accessed, barriers they faced when attempting
to access these services, and what services they need that they are not currently receiving.
Results: Participants encountered considerable barriers when accessing harm reduction and treatment services due to
the limited hours of services, lengthy wait times for treatment, and shortage of health care practitioners. They also
reported experiencing considerable negativity from health care practitioners. Participants cited incidences of
stigmatisation, and they perceived that health care practitioners received insufficient training related to drug use.
Recommendations for the improvement of services are outlined.
Conclusions: The findings indicate that initiatives should be developed to improve PWID's access to harm reduction
and treatment services in PEI. Additionally, health care practitioners should be offered sensitisation training and
improved education on providing services to PWID. The findings highlight the importance of considering innovative
alternatives for service provision in regions with limited resources.
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To date, the majority of the research examining the needs
of persons who inject drugs (PWID) in Canada has been
conducted in large urban centres, specifically, Toronto,
Vancouver, and Montreal. The limited empirical attention
paid to Canadian PWID who live in rural or remote areas
is disconcerting for three reasons: (1) studies investigating
prevalence rates of injection drug use in rural areas outside
of Canada suggest that there may be an increasing need for
services in smaller regions or remote areas [1-4], (2) less
populated regions may encounter unique institutional chal-
lenges when providing harm reduction and other treatment
services due to the costs associated with meeting the needs
of a geographically dispersed population and with recruiting* Correspondence: jessica.mccutcheon@usask.ca
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distribution, and reproduction in any mediumand retaining skilled health care practitioners [5,6], and (3)
at an individual level, PWID may experience increased
stigma and concern about confidentiality and anonymity
due to the area in which they reside, as well as significant fi-
nancial burdens if attempting to procure specialised health
care services [7-9].
The purpose of the present study, therefore, was to ex-
plore the service needs of self-identifying PWID in the
smallest of Canada's provinces, Prince Edward Island
(PEI). Set on the east coast of Canada, an area that con-
tains many rural and remote centres due to its geo-
graphical make-up, PEI is referred to as one of the
Atlantic provinces, as is Newfoundland, New Brunswick,
and Nova Scotia. At present, the authors are aware of
only three published studies [9-11] that have investigated
injection drug use in Atlantic Canada, the first of which
is centred in Newfoundland [10]. Set in St. John's, theioMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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study of Gustafson et al. [10] were 44 PWID (29 of
whom were surveyed, 15 interviewed), along with 34 ser-
vice providers, nurses, government workers, and policy
makers. Results indicated the presence of significant bar-
riers for PWID when trying to access health services in a
smaller Canadian centre. The researchers speculated that
small urban centres such as St. John's, Newfoundland do
not have the economic advantages of large cities and,
thus, are unable to adequately fund programmes and
services for PWID. As the first published study examin-
ing the needs of PWID in Atlantic Canada, the study of
Gustafson et al. [10] provides invaluable information on
potential barriers encountered by PWID in small urban
centres. However, it is important to point out that the
experiences of PWID in St. John's, Newfoundland may
not be representative of PWID in other small Canadian
centres given the geographic isolation and economic dis-
tinctiveness of the location.a
The two most recently published studies [9,11], focussing
on PWID residing in the Atlantic region, interviewed
PWID from all four of Canada's easternmost provinces
(Newfoundland, New Brunswick, Nova Scotia, and PEI).
Parker et al. [9] and Jackson et al. [11], two articles derived
from the same large-scale study, interviewed 115 PWID to
bring insight to how social and familial relationships affect
participants' drug-related practices. By interviewing PWID
residing in non-urban areas throughout Atlantic Canada, in
addition to urban locations, Parker et al. [9] were able to
highlight the unique barriers encountered by PWID whose
geographic distance from harm reduction services pre-
cluded the same degree of service access that could be ex-
pected by PWID living in urban centres. The researchers
found that PWID faced many obstacles when accessing
harm reduction services, primarily in the form of perceived
stigma from health care practitioners and pharmacists and,
for rural PWID specifically, the unavailability of services
within their region. In fact, PWID living outside urban cen-
tres who did not receive outreach services were found to
encounter greater challenges in accessing and disposing
sterile and used injecting equipment, respectively, and were
unable to benefit from the additional resources of-
fered by harm reduction programmes (e.g. referrals,
social support, and food). Drawing upon the same
sample of 115 PWID in Atlantic Canada, Jackson
et al. [11] specifically discuss the role of family mem-
bers in providing harm reduction support to PWID.
By exploring the role of familial relationships from
the perspective of the PWID, as opposed to the fam-
ily members, the researchers present an in-depth ana-
lysis of the opportunities and barriers resulting from
this innovative approach to harm reduction. The re-
searchers note that harm reduction interventions
initiated by family members may be particularlyimportant for PWID in rural areas who may have no,
or limited, access to services.
While Jackson et al. [11] and Parker et al. [9] in-
cluded participants from PEI, the number of partici-
pants from each province is not known nor are the
outlined needs specific to PWID in PEI: the reason
being that the data are collapsed across all four
Atlantic provinces. It is our intention to complement
the existing literature by focussing on PWID in the
province of PEI. There does not appear to be any
published research that exclusively examines the ser-
vices needs—harm reduction, medical, detoxification,
and methadone treatment services—of PWID within
this Canadian province. Importantly, although Jackson
et al. and Parker et al. included participants from PEI
in their study, the scope of their investigation was
limited primarily to harm reduction services, and due
to their amalgamation of emergent issues across all
four Atlantic provinces, those specific to PWID living
in the province of PEI may, ultimately, be obscured
[9,11].
Services for PWID in PEI
PEI (see Figure 1), located on the east coast of Canada,
is the nation's smallest province with a population of ap-
proximately 143,800 spread over 5,660 km2 [12,13]. The
context of injection drug use in PEI is difficult to assess
given that, when PEI is included in national or regional
studies on PWID, the province's data are often not
available or are amalgamated with data from the neigh-
bouring province of Nova Scotia [14]. This can be prob-
lematic since the other three Atlantic provinces have
urban centres with populations far exceeding those in
PEI and thus may not be comparable. Apart from the
Government of PEI's evaluation of the province's only
methadone maintenance treatment programme, the au-
thors found no research relating solely to the experi-
ences of PWID in PEI [15].
In terms of the treatment options for PWID in PEI,
the primary location is the Provincial Addictions Treat-
ment Facility located outside the capital city of
Charlottetown. The Provincial Addictions Treatment
Facility offers a detoxification programme for drug,
alcohol, and gambling addictions and contains 25 de-
toxification beds. The Provincial Addictions Treatment
Facility also is the location for the province's methadone
maintenance treatment programme. As well, PEI's pro-
vincial government offers preventative services through
their four syringe exchange centres.
The first syringe exchange centre opened in 2002 in
Charlottetown and was operated by the province's AIDS
organisation until 2009; after which, the provincial
government took over its operation. The provincial
government subsequently opened an additional centre in
Figure 1 Map of Prince Edward island.
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By 2010 and 2011, respectively, syringe exchange centres
were established on the western and eastern ends of the
island in an effort to provide access to PWID who were
too far from the two existing centralized locations [17,18].
The Charlottetown centre is open Monday to Friday in
the afternoons, and the Summerside location dispenses
sterile syringes two afternoons per week. The western and
eastern locations are each open one afternoon per week.
In stark contrast to Vancouver's supervised injection facil-
ity that remains open for a period of 18 h per day, the op-
erating hours of the PEI centres appear extremely limited.
As PWID often require late-night syringe access, these
limitations are problematic [10,19].
Methods
The present study was conducted in collaboration with
AIDS PEI, an organisation that provides support to
people living with HIV/AIDS and engages in HIV pre-
vention through harm reduction activities.
Participants
Participants were recruited using various methods.
Firstly, advertisements for the study were sent to organi-
sations that offer services to PWID provincially to post
in their offices or to distribute to clients. Further, given
their involvement with the study, AIDS PEI staff mem-
bers assisted in the recruitment of participants by men-
tioning the study to some of their clients. It should be
noted, however, that staff members were not presentduring the interviews. Advertisements also were placed
in downtown Charlottetown and Summerside, the
province's two most populous cities. Further, for
recruitment purposes and at the invitation of a PWID,
the first author attended Narcotics Anonymous meet-
ings throughout the province. At the end of these meet-
ings, individuals were approached to see if they would
be interested in participating in the present study.
Additionally, all participants and other PWID who
were approached were asked if they knew anyone
who would fit the eligibility criteria and would be
willing to participate. Eligibility criteria for the
present study were as follows: (1) self-identification
as a PWID, (2) resident of PEI, and (3) 18 years of
age or older. Due to the nature of the recruitment
methods employed, it is unknown how widely infor-
mation about the current study was disseminated;
therefore, it is difficult to speculate on the number
of eligible individuals who heard about the study but
chose not to participate.
Following all of the aforementioned recruitment
strategies, eight PWID (three females and five males)
were interviewed. The female participants ranged in
age from 22 to 33 (M = 29, SD = 6.35), and male par-
ticipants ranged in age from 30 to 45 (M = 37, SD =
6.95). One participant chose not to specify his age.
Six participants were identified as Caucasian and two
as Aboriginal-Caucasian. With respect to educational
attainment, two participants held a university or col-
lege degree, two had completed some college, three
McCutcheon and Morrison Harm Reduction Journal 2014, 11:10 Page 4 of 11
http://www.harmreductionjournal.com/content/11/1/10had completed high school, and one had completed
some high school. One participant was still using at
the time of the interview, four participants had
injected within the last 12 months, and three partici-
pants had gone 2 years or more without using injec-
tion drugs. Despite varying lengths of abstinence, all
participants self-identified as a PWID and, therefore,
were included in the study.
The decision to terminate recruitment after eight
participants were interviewed was made only after it
was felt that all feasible avenues for accessing partici-
pants had been exhausted. After a significant amount
of time had elapsed without any new PWID volun-
teering to participate, despite continued efforts to ac-
tively recruit them, a preliminary analysis of the data
was conducted to appraise if it would be methodo-
logically sound to conclude interviewing. The data
suggested, supported by the first authors' interactions
with PWID (participants and non-participants), that
saturation had been reached (i.e. the same themes
were emerging repeatedly; [20]). Thus, while the au-
thors acknowledged that eight participants may be
perceived as a relatively small sample and may limit
the ability to generalise to the wider population,
Baker and Edwards [21] note that, when conducting
interviews with hard-to-access populations, such as
PWID, a sample size as small as six can offer ex-
tremely valuable insights.Procedure
The questions posed during the semi-structured in-
terviews were designed to assess the services that
participants currently access or have accessed in the
past, the barriers faced when accessing these services,
potential means of improving the services that are
currently being offered, and whether additional ser-
vices are needed. PWID agreeing to participate were
interviewed at a time and location that was mutually
agreed upon. The interviews ranged from 30 to
90 min in duration.
Ethical approval was obtained from the authors' in-
stitutional research ethics board. All participants
completed written consent forms, which stipulated
that their responses would remain confidential and
that they had the right to withdraw from the study
at any time. As these interviews were conducted in a
relatively small region, personally identifying informa-
tion was removed or changed during data transcrip-
tion. Consent forms and demographic data were
stored separately from the interview transcripts, and
to safeguard anonymity, pseudonyms were given to
all participants. Pseudonyms were selected using an
online random name generator.Data analysis
Interviews were audio-recorded and transcribed verbatim.
The transcribed data were analysed using thematic
coding [22], which is a qualitative technique that faci-
litates identification of recurrent patterns among in-
terviews [20]. As per Marshall and Rossman's [23]
recommendation, the first author read participants' in-
terviews multiple times, thus ensuring an intimate fa-
miliarity with the data. Focusing on the types of
contextual factors influencing drug-related harm
[24,25] and in conjunction with the literature on the
needs of PWID [10,14,19], the first author identified
preliminary themes based on an initial review of the inter-
view transcripts. As these categories were refined, add-
itional themes emanated from the data inductively. After
data reduction, the themes were reviewed and reorganised
into overarching categories, thereby facilitating an under-
standing of the data in its entirety. After coding was com-
pleted, the second author reviewed the themes, and any
disagreements were resolved through discussion.Conceptual framework
The conceptual frameworks of Galea et al. [24] and
Rhodes [25,26] were used to guide data analysis in the
current study. Both frameworks focus predominantly on
how the social context in which PWID seek treatment
and harm reduction services influences health behav-
iours. Galea et al. [24] posit that social policy and regula-
tion affect contextual-, mediating-, and individual-level
factors related to drug use behaviour. For instance, if
policies were enacted to increase the availability of treat-
ment services for PWID in a specific area, this may, in
turn, decrease the number of PWID in that location.
The researchers cite a number of key contextual factors
associated with drug use behaviour including structural
(e.g. service availability), social (e.g. social norms and at-
titudes), and physical dimensions (e.g. housing). Like-
wise, Rhodes [26] argues that risk reduction should be
approached as a multi-level activity, encompassing not
only individual components but also incorporating com-
munity and environmental elements. He notes that it is
the risk environment, the social and physical spaces that
can interact with an individual to increase the likelihood
of drug-related harm, which largely defines the success
of any policy or intervention. Expanding on the context-
ual factors put forth by Galea et al., Rhodes includes four
types of environment: physical, social, economic, and
policy [24,25]. The current study focuses on these con-
textual factors; specifically, whether existing drug-related
services (i.e. syringe exchange centres and treatment fa-
cilities) meet the needs of PWID in the province of PEI
and whether specific social forces perpetuate the mar-
ginalisation of this group.
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Inadequate or unavailable service provision
All participants reported that current harm reduction
strategies and service provision for PWID in PEI were
insufficient. Three subthemes were found in relation to
the inadequacy or unavailability of service provision: (1)
limited access to sterile syringes, (2) lengthy wait times
for treatment, and (3) shortage of health care practi-
tioners. Within the subthemes, participants' recommen-
dations for improved services also are identified.
Limited access to sterile syringes
A commonly discussed element of the structural environ-
ment that shapes drug-related harm concerned participants'
access to sterile syringes. Participants had two options avail-
able to them when obtaining sterile syringes; they could ex-
change their used syringes for sterile ones at the syringe
exchange centres or they could purchase them at pharma-
cies. While most participants reported frequenting the
province's syringe exchange centres on occasion, all partici-
pants indicated that, due to their convenient locations,
pharmacies were the outlets most commonly accessed for
sterile syringes. However, some participants mentioned
their inability to secure sterile syringes when they needed
them most. Given the size and population of the cities and
towns in PEI, most pharmacies close at 9.00 p.m., with only
one Charlottetown location staying open until midnight. In-
deed, one participant stated that the limited hours of oper-
ation of both syringe exchange centres and pharmacies
contributed to the hazardous practice of sharing syringes:
The pharmacy isn't open 24 hours and….the biggest
necessity for clean needles is actually during…hours
which aren't regular business hours….so there was
times that I found myself having to use someone else's
syringes and those were times when you know the
pharmacies were closed and the needle exchange was
closed. (Greg, 30, 2 years without injecting)
All of the participants were aware of the importance
of using sterile syringes; however, most of them indi-
cated that this concern did not override their need to
use. As a result, all participants reported using their own
syringes repeatedly, and a majority reported that, at
some point, they had shared syringes with others. Al-
though participants were aware that by reusing their
own syringes they would not contract blood-borne infec-
tions from others, some participants outlined the dele-
terious consequences associated with this practice. For
example, one participant noted:
I had to use the same [syringes] and I've had them
even break off in my arm….[the scars] were great big
things. They're finally going down…that was just amess. I've got marks under my knees, on my feet, my
legs, on my boobs, everywhere. (Patricia, 33, 7 months
without injecting)
Several participants suggested recommendations for
improving access to sterile syringes. One participant rec-
ommended that a vending machine selling sterile syrin-
ges be considered. He stated:
Have some kind of automatic vending machine and
maybe you put in like 25 cents to get one pre-
packaged needle or something….to provide access to
clean needles at all times. (Greg, 30, 2 years without
injecting)
Changes to the policy environment were among the rec-
ommendations made by participants. For instance, having
PWID act as secondary distributors was believed to facili-
tate the distribution of sterile syringes and could potentially
reduce the stigma encountered when purchasing syringes.
Further, distributors could be given additional injection
equipment to disseminate to the community. One partici-
pant describes how he engaged in secondary distribution
and how it provided him the opportunity to educate other
PWID:
I distributed [syringes and swabs] in the community, I
picked up dirty needles, gave out clean ones, gave out
condoms, literature, stuff like that. (Lucas, 45, still
using)
Both of the recommendations for improving access to
sterile syringes could also accommodate PWID who are
unable to access, whether because of geographical distance
or timing, one of the province's four syringe exchange cen-
tres. In addition, participants also indicated that PWID
would benefit from education about safe injection practices.
One participant explained that while a ‘clean needle might
be used…maybe they'll use a dirty spoon,’ and without ad-
equate information, PWID might not know the myriad
ways that infections can be transmitted.
Lengthy wait times for treatment
Most participants reported that, once their drug use esca-
lated to a certain point or the consequences of their use be-
came overwhelming, they decided to seek treatment for
their drug dependency. Although many of the participants
tried to gain access to the services offered by the Provincial
Addictions Treatment Facility, a 1- to 2-year waiting period
prior to commencing a programme of any kind was typical
as evidenced by the following two extracts:
I had actually tried to get on the methadone
maintenance programme several times through the…
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onto… the maintenance programme through them.
(Greg, 30, 2 years without injecting)[The Treatment Facility staff] ask you at some point,
“Do you wish to be placed on the methadone list?”
You say, “Yes.” They say, “Well, great, we'll probably
talk to you in about a year's time.” (Lucas, 45, still
using)
These lengthy waiting lists may have dire conse-
quences for the lives of drug-injecting men and women.b
In the next excerpt, one participant explains:
Well, if I had have been on the programme, I
probably wouldn't have turned to injection. (Daniel,
33, 6 months without injecting)
Below, one participant further attests to these challenges:
[My partner] was trying to get into detox….he tried to
get in and they wouldn't let him in. So that, to me,
[showed me that there] was something wrong with
the programme…He had depression really bad…they
all knew he had problems, somebody should have
stood up and let him in right away instead of making
him wait…If he had have been in detox…he wouldn't
be dead [from suicide] right now. (Patricia, 33,
7 months without injecting)
Without timely access to the Provincial Addictions
Treatment Facility and it being the only methadone
maintenance programme in PEI, participants were
compelled to identify other ways of receiving me-
thadone treatment. For instance, some participants
were able to get treatment from physicians who could
prescribe methadone. One participant explains this
process:
My family doctor… made me an appointment for
another doctor…that has a license to prescribe
methadone to injection drug users as a means of
getting them to stop using drugs. There's only four
doctors on the Island who have that type of license….
That particular doctor said that there was no problem
with me getting methadone…he had me on
methadone the next day. (Greg, 30, 2 years without
injecting)
One participant was forced to leave PEI and go to a
more urban city in the neighbouring province of New
Brunswick in order to get methadone treatment after
having been refused by physicians and having been told
that it would be at least 2 years before he could receivetreatment from the province's methadone maintenance
treatment programme. He explains:
There's a two-year waiting list because there's no
funding for anybody, they're not taking patients or
anything for it now, cause it's just not in their budget.
They're at their limit, they're stretched, there's no re-
sources for it at all….So that's why I chose to [go to
New Brunswick]. (Adam, 41, 4 months without
injecting)
Adam further states that, after his move to New
Brunswick, he ‘got on [methadone] right away’.
With only 25 detoxification beds at the Provincial
Addictions Treatment Facility, a limited number of indi-
viduals can be admitted at any one time. The lack of
readily available services posed a structural barrier for
participants. Moreover, the economic environment fur-
ther perpetuates the inaccessibility of treatment services.
Participants who had succeeded in being admitted to the
detoxification programme commented that increased
funding could be used to establish follow-up services.
One respondent described the difficulty abstaining from
injection drugs on his own after treatment:
What they do in the detox is dry you out so you're
healthy enough…for seven to ten days you're off your
medication. After that point, you have to struggle, and
go to your meetings, and keep your head down, and
keep going ahead, but it's just so hard to do. (Adam,
41, 4 months without injecting)
Implementing a walk-in clinic that would house a de-
toxification centre as well as counsellors, physicians, and
pharmacists also was recommended. By having all of the
services in one location, it was perceived as a means of
encouraging individuals engaged in treatment to utilise
a broader range of services during all steps of their
recovery.
Shortage of health care practitioners
Several participants discussed how the inadequacy of
services and lengthy waiting lists could be related to a
shortage of health care practitioners across the province.
For instance, Hanna noted, during one of her visits to
the Provincial Treatment Facility, that ‘there's a bunch
of beds empty.’ This observation is incompatible with
participants' accounts of their inability to access exped-
itious treatment at the facility. Hanna indicated that des-
pite the available infrastructure, there were ‘not enough
nurses’ to accommodate full occupancy.
As mentioned, without access to the Provincial Treat-
ment Facility, several participants sought methadone treat-
ment through private physicians. However, given the small
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PWID may not be able to access this drug through the Pro-
vincial Addictions Treatment Facility or physicians operat-
ing independently of the facility:
Call [the doctors in PEI] and see if they're taking any
new patients for methadone of which the answer is
“no.” (Lucas, 45, still using)I guess [physicians] have to reject patients because
they have too much of a clientele. (Adam, 41,
4 months without injecting)
Participants surmised that increased funding to hire add-
itional staff would lead to reduced wait times at treatment
facilities. However, they promptly acknowledged that with-
out greater funding for additional health care practitioners,
a feature shaped by the economic environment, these im-
provements would remain unrealised:
My advice would be to have an open methadone
clinic…. but that will never happen cause we're talking
about jobs. (Lucas, 45, still using)
Negativity from health care practitioners
Many participants cited negativity that was directed at
them from PEI health care practitioners. Specifically,
participants observed two main types of negativity: (1)
negativity related to insufficient training of health care
practitioners and (2) stigma.
Insufficient training of health care practitioners
When participants were asked about their experiences
with health care practitioners, they commonly cited the
insufficiency of the medical community's training about
drug dependency. Firstly, it was felt that part of this in-
sufficiency was related to physicians' and nurses' per-
ceived inability to gauge the appropriate amount of
medication to prescribe. Some participants maintained
that, when they tried to receive medical service, they
were not given enough pain medication due to their sta-
tus as a PWID, despite their stated need. When seeking
treatment for a non-drug-related injury, one participant
spoke of how he was forced to endure unnecessary pain
because he had admitted to health care workers that he
was a PWID:
I was in the hospital…and I told them I was an addict
and stuff, like I was clean when I went in, and they
had to give me opiates for pain…when I was
discharged they told me they could have gave me
more for pain but because of me having an addiction,
they didn't want to give me more. So they let me
suffer. (Daniel, 33, 6 months without injecting)One respondent, who had received services at the Pro-
vincial Addictions Treatment Facility several times after
being fast-tracked because of the severity of her drug de-
pendency expressed her frustration in the following way:
[The nurses are] not very good, they don't
understand….the nurses right on [the] detox unit, it
seems like they don't really know what kind of aches
and pains you have in withdrawals. (Hanna, 33,
3 months without injecting)
Recommendations were primarily in regard to the pol-
icy environment. That is, numerous participants recom-
mended that the curriculum for health care practitioners
be revised to include additional training focussing on
working with PWID. They also recommended that
guidelines for the provision of drugs be created because
it was felt that some physicians prescribe more drugs
than are necessary. In hospital situations, it was per-
ceived that health care practitioners allocated drugs in
cases when they were unwanted and/or dangerous. One
participant recounted a hospital scenario in which her
partner was given Dilaudid as part of his treatment, des-
pite both his and her wishes that opiates not be among
the drugs provided. She stated:
After we both said that he was a recovering drug user,
they should have marked that right on his chart.
(Patricia, 33, 7 months without injecting)
Participants feared that these types of omissions might
lead non-using individuals to relapse after medical
treatment.Perceived stigma from health care practitioners
An element of the social environment that was discussed
involved the experience of stigma from health care practi-
tioners. In fact, some participants felt that, because of their
status as a known PWID, attempts at seeking any acute
medical services were compromised. One participant stated
that he had waited in the hospital for over 8 h while trying
to obtain medical attention for a drug-related issue. He
relayed:
I've heard them say…. “[He] is just a drug addict or a
narcotic user, just put them in a corner until later.”
(Adam, 41, 4 months without injecting)
Based on participants' accounts, stigma is particularly
prevalent when seeking medical treatment for drug-related
issues at hospitals. Lucas commentated that he was often
treated as a ‘second-class citizen.’ He provided an example
from one of his hospital visits:
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reference being someone who comes to emerg[ency]
looking for narcotics. (Lucas, 45, still using)
However, hospitals were not the only location where
participants reported being stigmatised because of peo-
ple's negative attitudes toward PWID. Some participants
emphasised the discrimination they experienced when
purchasing syringes. Pharmacists and pharmacy em-
ployees were perceived to be less accepting of PWID
buying syringes in comparison to staff at syringe ex-
change centres. For instance, one participant recounted:
I had one pharmacist get me before I exited his
pharmacy and he said he would appreciate it if I never
came into his store again because of what I had just
bought at the pharmacy counter. (Lucas, 45, still
using)
Also, when PWID are diagnosed with injection-related
health problems, the challenges they encounter when
seeking medical services may be further intensified. One
participant, who is co-infected with HIV and hepatitis C,
often experienced isolation from physicians, nurses, and
dentists because of his diagnoses. He indicated:
I went to a dentist…and he told the receptionist to
close the door and to make sure everything's sterilised
in there. [He] just had to take an x-ray of my mouth,
didn't even put nothing on me, just against my face
and he wanted the whole wall, floor done, the seats,
[he] put a biohazard sign on the door….It's just isola-
tion, they treat you like an animal. (Christopher,
7 years without injecting)
Discussion
Our study identifies key barriers affecting PWID who are
looking to safely inject or treat their drug dependency and
provides PWID-generated recommendations addressing
the barriers, namely sterile syringe access, treatment access,
perceived discrimination by health care practitioners and
the insufficiency in their training in relation to drug use,
and lack of follow-up services. During one-to-one inter-
views, eight participants responded to questions about the
services they typically access or have accessed in the past,
the extent to which they can, and wish to, access sterile sy-
ringes, their experiences with various treatment services
and health care practitioners (e.g. the province's treatment
facility and interactions with medical staff, respectively), im-
pediments to receiving treatment, and recommendations
for improved sterile syringe access and service provision.
The frameworks of Galea et al. [24] and Rhodes [26], with
their focus on environmental factors, guided the data inter-
pretation. Challenges obtaining sterile syringes and accessto treatment highlight the need for economic and policy
changes to the service provision in PEI, while PWID who
perceived discrimination, in relation to their receipt of
medical care, denotes the presence of social barriers.
When questioned about where they accessed their
sterile syringes, most participants reported buying sterile
syringes at pharmacies instead of using one of the pro-
vince's four syringe exchange centres. Due to the syringe
exchange centres' limited hours of operation, pharmacies
offered significantly greater opportunity to obtain sterile
syringes during the later parts of the evening. It should
be mentioned, however, that participants cited the hours
of both the syringe exchange centres and pharmacies as
being their biggest challenge when trying to access ster-
ile syringes. Given that syringe exchange centres have
limited hours (e.g. only 2.5 h per week for some partici-
pants) and pharmacies do not offer 24 h per day services
as they do in large cities, a structural barrier such as this
may be particularly problematic for PWID in rural or
smaller urban centres.
Due in part to the inaccessibility of sterile syringes late
at night, all participants reported re-using their own sy-
ringes, with six of the eight reporting having shared sy-
ringes with other PWID. Although participants were
aware of the risks associated with the latter practice,
they were less aware of the risks inherent in sharing
drug injection paraphernalia such as spoons, water, and
filters. This finding is consistent with the research [27]
suggesting that, despite having considerable knowledge
on safe-injecting behaviour, many PWID continue to en-
gage in risky injection practices. Indeed, four of the par-
ticipants indicated that, at the time, they did not care
about the consequences of either practice (i.e. re-using
syringes or sharing them with other PWID).
Participants offered a number of recommendations to
improve access to sterile syringes, which included extend-
ing the hours of operation at the syringe exchange centres
(i.e. ensuring that the centres are operational outside of
regular business hours), purchasing vending machines for
the distribution of sterile syringes, and organising PWID to
serve as secondary distributors. Several of these suggestions
for improving syringe access are supported by the literature
[28-30]. For example, Islam and Conigrave found that
syringe-dispensing machines are effective means for distrib-
uting syringes to those who are unable, or unwilling, to fre-
quent syringe exchange centres or pharmacies [31], and
they can be incorporated into the existing distribution tac-
tics of syringe exchange programmes. Although population
density is relatively low in PEI, syringe-dispensing machines
could be erected in the downtown regions of the most
urban areas of the province, Charlottetown and Summer-
side, where it is likely that PWID are concentrated. Re-
searchers also found that secondary distribution by other
PWID or drug dealers could increase the use of sterile
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ment through formal distribution services [19,32]. Syringe
exchange programmes also can facilitate secondary distri-
bution by furnishing providers with biohazard containers
for used syringes and not limiting the number of syringes
provided. According to Klein, PWID may prefer dispensing
machines or secondary distribution as means of maintain-
ing their anonymity [33]. Further, these methods may be of
particular importance for PWID in smaller communities
who cannot purchase sterile syringes from pharmacies
without suspicion from community members [31,33].
In a federal study examining drug dependency pro-
grammes and policies, the Canadian Mental Health
Association reported that ‘about half of the adult popu-
lation who need services [including treatment designed
to treat or manage drug dependence] must wait for eight
weeks or more’ ([34], p. 161). Based on this estimate, it
appears that PWID in PEI are facing comparatively lon-
ger wait times prior to starting a provincially funded
treatment programme (i.e. periods of time in excess of
2 years) than PWID situated in other provinces. Indeed,
seven of the eight participants who had received treat-
ment from the Provincial Addictions Treatment Facility
at some point in the past, indicated that the long wait-
lists was the biggest challenge to starting treatment, and
a majority reported that their drug use typically intensi-
fied when treatment was inaccessible. Although some
participants were able to access private clinics that had
physicians who would prescribe methadone, most of our
participants indicated that there are too few physicians
in PEI (i.e. four in total) who can write methadone pre-
scriptions, and at the time of our interviews, these physi-
cians were not taking new patients. Based on these
barriers, participants recommended that the provincial
government increase funding for treatment services for
PWID, a recommendation that may not be easily imple-
mented. For instance, Gustafson et al. caution that small
regions may not have the economic resources to in-
crease funding, and therefore, initiatives such as these
may not be feasible [10].
The nature of the medical care received by partici-
pants also was cited as a problem. Participants reported
that doctors and nurses did not know enough about
drug dependency and either dispensed narcotic drugs
too liberally or did not supply enough narcotics for pain
relief when a patient was identified as a PWID. Several
participants in the present study reported that they were
the recipients of verbal (e.g. name-calling) and non-
verbal discriminatory behaviour (e.g. receiving no ser-
vice) from health care practitioners and pharmacists. In
their examination of incidents of discrimination encoun-
tered by PWID in Australia, Day et al. found that 37% of
these events occurred in health care settings and more
than half resulted in refusals of service [35].Limitations and future directions
The present study advances understanding of the cur-
rent atmosphere for PWID in PEI and offers PWID-
generated recommendations as to what can be done to
improve services for this population. Our interviews sug-
gest that the current services for PWID do not meet the
demand for treatment; this is valuable information given
that no studies of this kind have been conducted in the
province of PEI to date. However, since only eight PWID
were interviewed, further research is warranted. Despite
assurances of confidentiality and anonymity, most PWID
were unwilling to participate in the present study be-
cause of their apprehension when asked to discuss their
injection behaviour with someone associated with a ser-
vice provision organisation due to fear of negative repri-
sals (e.g. loss of social assistance or child custody).
Researchers should ensure that every effort is made to
provide reassurance to PWID that their participation
will not result in these deleterious consequences. One
method to encourage increased participation among
PWID may be the formation of an interdisciplinary
team. For instance, the addition of a social worker may
have assuaged the fears of those PWID who were appre-
hensive about repercussions related to their social assist-
ance status or their parental rights, or the inclusion of a
lawyer could have offered legal protection to those who
were concerned about reporting on their illegal behav-
iour. Also, research teams that are unaffiliated with orga-
nisations providing services to PWID could potentially
increase willingness to participate due to a greater level
of perceived anonymity. Service providers in Atlantic
Canada indicate that the preservation of PWID's ano-
nymity may be particularly important for those in less
populated regions, making the need to provide add-
itional assurances of confidentiality and security critical
when recruiting this population [36].
The number of PWID who agreed to participate also
may have been low given that only Canadian 5$ was
provided to those who were interviewed. By providing a
greater monetary incentive, it is possible that more indi-
viduals would be willing to participate. Further, incen-
tives such as free syringes, assistance with travel to and
from the interview, and other gift-related alternatives
(grocery cards, gift cards, products, and so forth) could
be offered. Incorporating appropriate incentives into the
research protocol could promote greater interest in par-
ticipating. Additionally, the sampling procedures may
have affected the themes that were generated. Since par-
ticipants were recruited primarily through harm reduc-
tion and treatment organisations, this may be why only
one participant reported currently injecting drugs (and
all other participants reported some length of sobriety).
Future research concentrating on PWID who are not
utilising treatment or harm reduction services could
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in PEI.
It also should be acknowledged that the primary re-
searcher, who conducted the interviews, is not a current
or former PWID and may not have been as readily ac-
cepted into the community or as trusted as an insider
may have been. In an effort to recruit and build rapport
with PWID, researchers might consider a team approach
wherein a current or former PWID actively participates
during interview sessions. Not only would this strategy
likely improve participants' general comfort, but it also
may assist the elucidation of themes that are not as eas-
ily arrived at when PWID are engaged in discussion with
an outsider. However, an interviewer who may be less fa-
miliar with the minutia of injection drug use is more
likely to probe for details that are presumed known by
the insider. Some researchers suggest that a research
team including both an insider and outsider is ideal
[37,38].
Participants also may have been selective with the infor-
mation that they provided in order to correspond to the
perceived expectations of the researcher. Male participants,
in particular, may have tailored their answers in response to
being interviewed by a woman. Therefore, if researchers
choose to use the team approach in future studies, it may
be useful to have interviewers of different genders or to
match the gender of the participant with the interviewer.
This approach also may highlight any gender differences
that exist between the needs and lifestyles of male and fe-
male PWID. For instance, research has found that female
PWID tend to participate in more syringe sharing, likely
due to their larger social networks; however, they also en-
gage in more protective behaviours such as carrying clean
syringes and frequenting syringe exchange centres [39,40].
While not a focus of the present study, our interviews re-
vealed differences between men and women insofar as their
initiation to injection drugs, the methods they use to obtain
drugs, how they secure treatment services, and their fears
related to speaking to service providers. Gender-related dif-
ferences such as these should be explored in small urban
centres in greater detail.
Finally, ongoing research is needed on PWID in PEI
due to the continuous changes in service provision. The
present study was conducted in 2010, prior to the estab-
lishment of the syringe exchange centre on the western
side of the province. Additional research could deter-
mine how this new centre may affect sterile syringe ac-
cess in PEI and how trends in injection drug use and
PWID's service needs change over time.
Conclusions
While PWID in the present study report encountering bar-
riers similar to those described by PWID in large urban
centres, the challenges faced by PWID in this area appearto be intensified due to the limitations of a smaller region's
harm reduction, treatment, and health care services. The
present study revealed that the current services for PWID
are not adequately meeting their demand for treatment. Re-
searchers should continue investigating novel channels
through which interventions could be provided to PWID
who, due to the province of PEI's funding constraints, can-
not benefit from the services offered in larger cities. Finally,
when creating new initiatives or improving current services
for PWID in smaller urban centres, policy makers should
be cognisant that their experiences may differ from PWID
in more populated urban centres.
Endnotes
aSt. John's, Newfoundland and Labrador is located on
the island of Newfoundland and has a population of
196,966 (spread over 805 km2) [41]. Newfoundland and
Labrador, Canada's easternmost province, has the coun-
try's highest unemployment rate and is one of its most
economically depressed provinces [42]. Recent environ-
mental and economic restructuring has resulted in in-
creased job loss and emigration from the province [43].
bWhile wait time data for PEI's drug dependency ser-
vices are not available, the Government of Nova Scotia,
in a neighbouring province to PEI, reports that nine out
of ten patients wait between 26 to 54 days (depending
on their health district) to receive structured residential
treatment [44].
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